Alere Company Profile (NYSE:ALR)

About Alere

Alere logoAlere Inc. is a provider of health information through diagnostic tests. The Company operates through professional diagnostics, patient self-testing, consumer diagnostics and, corporate and other segments. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The patient-self testing segment provides services designed to provide physicians with actionable data that allow them to make decisions in real time, deliver care, and put the individuals they treat on a pathway to better health. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its 50/50 joint venture with The Procter & Gamble Company (P&G).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Supplies
  • Exchange: NYSE
  • Symbol: ALR
  • CUSIP: 01449J10
Key Metrics:
  • Previous Close: $43.15
  • 50 Day Moving Average: $40.94
  • 200 Day Moving Average: $43.15
  • 52-Week Range: $31.47 - $54.13
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 17.19
  • P/E Growth: 2.08
  • Market Cap: $3.74B
  • Outstanding Shares: 86,740,000
  • Beta: 1.31
  • Net Margins: -2.30%
  • Return on Equity: 8.40%
  • Return on Assets: 2.02%
  • Debt-to-Equity Ratio: 2.08%
  • Current Ratio: 2.55%
  • Quick Ratio: 1.96%
Additional Links:
Companies Related to Alere:

Analyst Ratings

Consensus Ratings for Alere (NYSE:ALR) (?)
Ratings Breakdown: 4 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $52.13 (20.80% upside)

Analysts' Ratings History for Alere (NYSE:ALR)
DateFirmActionRatingPrice TargetDetails
9/1/2016BTIG ResearchReiterated RatingBuy$48.00View Rating Details
8/4/2016Jefferies GroupReiterated RatingHoldView Rating Details
7/28/2016Canaccord GenuitySet Price TargetBuy$56.00View Rating Details
7/12/2016Leerink SwannReiterated RatingBuy$56.00View Rating Details
4/29/2016Craig HallumUpgradeHold -> BuyView Rating Details
2/2/2016Raymond James Financial Inc.DowngradeOutperform -> Market PerformView Rating Details
2/1/2016Goldman Sachs Group Inc.DowngradeBuy -> Neutral$47.00 -> $56.00View Rating Details
11/5/2015WedbushLower Price TargetNeutral$43.00 -> $39.00View Rating Details
2/12/2015Citigroup Inc.DowngradeMarket WeightView Rating Details
10/3/2014ING GroupInitiated CoverageBuy$48.00View Rating Details
(Data available from 9/26/2014 forward)


Earnings History for Alere (NYSE:ALR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/6/2016Q216$0.58($0.46)$611.10 millionViewN/AView Earnings Details
8/17/2016Q116$0.56($0.18)$578.00 millionViewN/AView Earnings Details
8/8/2016Q415$0.58($0.28)$662.04 million$623.00 millionViewN/AView Earnings Details
11/4/2015Q315$0.61$0.54$646.29 million$602.00 millionViewN/AView Earnings Details
8/4/2015Q215$0.54$0.54$625.67 million$629.00 millionViewN/AView Earnings Details
5/5/2015Q115$0.49$0.57$612.93 million$610.40 millionViewN/AView Earnings Details
2/10/2015Q414$0.63$0.60$698.56 million$666.90 millionViewN/AView Earnings Details
10/28/2014Q314$0.52$0.48$743.30 million$736.20 millionViewN/AView Earnings Details
8/4/2014Q214$0.58$0.42$747.55 million$738.30 millionViewN/AView Earnings Details
4/29/2014Q114$0.55$0.55$738.70 million$716.60 millionViewN/AView Earnings Details
2/6/2014Q413$0.62$0.68$770.70 million$772.30 millionViewN/AView Earnings Details
10/29/2013Q313$0.53$0.59$737.66 million$753.90 millionViewN/AView Earnings Details
7/31/2013Q2 2013$0.48$0.64$720.24 million$764.00 millionViewN/AView Earnings Details
5/9/2013Q1 2013$0.51$0.53$727.66 million$739.20 millionViewN/AView Earnings Details
2/15/2013Q4 2012$0.57$0.55$714.75 million$755.80 millionViewN/AView Earnings Details
11/8/2012Q312$0.53$0.43$690.76 million$691.40 millionViewN/AView Earnings Details
8/8/2012$0.53($0.23)ViewN/AView Earnings Details
4/30/2012$0.67$0.77ViewN/AView Earnings Details
2/8/2012$0.71$0.74ViewN/AView Earnings Details
10/26/2011$0.57$0.67ViewN/AView Earnings Details
7/27/2011$0.58$0.46ViewN/AView Earnings Details
4/27/2011$0.61$0.61ViewN/AView Earnings Details
2/17/2011$0.66$0.71ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Alere (NYSE:ALR)
Current Year EPS Consensus Estimate: $2.08 EPS
Next Year EPS Consensus Estimate: $2.51 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.41$0.41$0.41
Q2 20161$0.54$0.54$0.54
Q3 20163$0.45$0.52$0.49
Q4 20163$0.53$0.65$0.57
(Data provided by Zacks Investment Research)


Dividend History for Alere (NYSE:ALR)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Alere (NYSE:ALR)
Insider Ownership Percentage: 1.93%
Institutional Ownership Percentage: 92.18%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2016Melissa GuerdanSVPSell2,500$54.00$135,000.00View SEC Filing  
11/13/2015Robert Bernard HargadonSVPBuy1,000$38.99$38,990.00View SEC Filing  
11/12/2015James F HinrichsCFOBuy10,000$39.97$399,700.00View SEC Filing  
9/3/2015Mark GladwellVPSell2,651$52.27$138,567.77View SEC Filing  
9/3/2015Melissa GuerdanSVPSell5,135$52.00$267,020.00View SEC Filing  
9/1/2015Melissa GuerdanSVPSell5,000$50.48$252,400.00View SEC Filing  
8/31/2015Mark GladwellVPSell27,513$52.23$1,437,003.99View SEC Filing  
8/14/2015Sanjay MalkaniInsiderSell31,460$54.60$1,717,716.00View SEC Filing  
6/8/2015Sanjay MalkaniInsiderSell24,331$50.87$1,237,717.97View SEC Filing  
6/4/2015Sanjay MalkaniInsiderSell15,669$52.18$817,608.42View SEC Filing  
6/1/2015John BridgenSVPSell7,500$51.19$383,925.00View SEC Filing  
4/6/2015Melissa GuerdanSVPSell2,500$50.00$125,000.00View SEC Filing  
3/23/2015Melissa GuerdanSVPSell13,476$48.35$651,564.60View SEC Filing  
3/17/2015John BridgenSVPSell25,000$48.53$1,213,250.00View SEC Filing  
3/16/2015Carla FlakneCAOSell8,500$48.99$416,415.00View SEC Filing  
1/16/2015Carla FlakneCAOSell10,000$42.45$424,500.00View SEC Filing  
12/24/2014Don DudekDirectorBuy40,000$0.01$500.00
12/11/2014John BridgenSVPSell50,000$37.07$1,853,500.00View SEC Filing  
8/15/2014Dave TeitelCFOSell10,000$35.07$350,700.00View SEC Filing  
8/15/2013Dave TeitelCFOSell10,000$31.73$317,300.00View SEC Filing  
8/5/2013Michael Lester CottonInsiderSell12,500$33.82$422,750.00View SEC Filing  
5/31/2013Michael Lester CottonInsiderSell8,750$25.86$226,275.00View SEC Filing  
3/5/2013John QuelchDirectorSell20,220$23.49$474,967.80View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Alere (NYSE:ALR)
News IconAre Analysts Bearish Alere Inc (NYSE:ALR) After Last Week ... - Post News (NYSE:ALR) - September 25 at 8:11 AM
News IconNotable SEC Filing: As Alere INC Ordinary (ALR) Stock Price Declined, Airain LTD Has Lifted Its Holding - Chester News (NYSE:ALR) - September 23 at 3:51 PM logoScreening company, 230 jobs jump state line to south KC (NYSE:ALR) - September 22 at 3:24 PM logoAlere Inc. (NYSE:ALR)'s Accounts Payable Is $194.235 - (NYSE:ALR) - September 21 at 4:20 PM
News IconPharos Capital Acquires TechLab, Healthcare Deals Rise (NYSE:ALR) - September 20 at 3:26 PM logoPharos Capital Takes Controlling Stake in TechLab from Alere (ALR) (NYSE:ALR) - September 20 at 3:26 PM
News IconHC Stocks Broker Alerts! Alere Inc (ALR), Agilent Technologies Inc (NYSE:A) - share market updates (press release) (NYSE:ALR) - September 19 at 8:12 AM logoPharos Capital Takes Controlling Stake in TechLab from Alere (ALR) - (NYSE:ALR) - September 19 at 8:12 AM logoAlro to start a Project co-funded by the Regional Development European Fund (NYSE:ALR) - September 19 at 8:12 AM logo7:30 am Alere sells its stack in TechLab to Pharos Capital; terms not disclosed (NYSE:ALR) - September 19 at 8:12 AM logoPharos Capital Acquires TechLab, Leading Developer of Gastrointestinal Disease Diagnostics (NYSE:ALR) - September 19 at 8:12 AM logoAlere Inc. (NYSE:ALR) Price Forecast At $54 - Stocks Daily (NYSE:ALR) - September 16 at 3:26 PM logoAlere Inc. (NYSE:ALR) Mean Price Target Is $54 (NYSE:ALR) - September 16 at 12:07 PM
News IconWhat are Research Firms Saying About Alere Inc. (NYSE:ALR)? - Frisco Fastball (NYSE:ALR) - September 14 at 8:42 PM logoAlere Inc. (NYSE:ALR) Accounts Payable Is $194.235 - (NYSE:ALR) - September 14 at 8:42 PM logoAlere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock (NYSE:ALR) - September 14 at 8:42 PM logoAlere Inc. (NYSE:ALR) Mean Price Target Is $54 - (NYSE:ALR) - September 14 at 3:26 PM logoCan Alere Inc. (NYSE:ALR): Post EPS Of $0.59? - Investor Newswire (NYSE:ALR) - September 13 at 3:26 PM
News IconEarnings According to Analysts for Alere Inc. (NYSE:ALR)? - Frisco Fastball (NYSE:ALR) - September 13 at 8:15 AM logoALERE INC. Financials (NYSE:ALR) - September 9 at 3:24 PM
News IconThe Sell-side Consensus is in on Alere Inc. (NYSE:ALR); Earnings & Target Updates - National Daily Press (NYSE:ALR) - September 9 at 8:14 AM logoAbbott and Alere to mediate merger dispute - Seeking Alpha (NYSE:ALR) - September 8 at 3:24 PM logoAbbott and Alere to mediate merger dispute (NYSE:ALR) - September 8 at 2:27 PM logoAbbott, Alere agree to mediate merger dispute (NYSE:ALR) - September 8 at 1:01 PM logoAlere, Inc. – Value Analysis (NYSE:ALR) : September 8, 2016 (NYSE:ALR) - September 8 at 11:35 AM
News IconStock Earnings Roundup: Alere Inc (NYSE:ALR) - Post Registrar (NYSE:ALR) - September 7 at 3:25 PM logoAlro signed a financing agreement for the improvement of research infrastructure (NYSE:ALR) - September 7 at 12:23 PM
News IconTeva Pharmaceutical Industries Limited (NYSE:TEVA) , Alere Inc. (NYSE:ALR) - Cosumnes Connection (subscription) (NYSE:ALR) - September 6 at 3:25 PM
News IconViewing Major Stock of Friday- Alere Inc.'s (ALR) - Hot Stocks Point (NYSE:ALR) - September 6 at 3:25 PM logoMerger Arbitrage - Alere And Abbott - Seeking Alpha (NYSE:ALR) - September 6 at 3:25 PM logoEARNINGS SUMMARY: Details of Alere Inc. Q2 Earnings Report (NYSE:ALR) - September 6 at 8:14 AM logoALERE INC. Files SEC form 10-Q, Quarterly Report (NYSE:ALR) - September 6 at 8:14 AM logoAlere Reports Second Quarter 2016 Financial Results (NYSE:ALR) - September 6 at 8:14 AM logoALERE INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NYSE:ALR) - September 6 at 8:14 AM logoAlere revenues off 2% in Q2 (NYSE:ALR) - September 6 at 7:57 AM logoUPDATE 1-Delaware judge expedites Alere lawsuit against Abbott (NYSE:ALR) - September 2 at 3:40 PM logoDelaware judge expedites Alere lawsuit against Abbott - Reuters (NYSE:ALR) - September 2 at 3:27 PM logoDelaware Judge expedites Alere lawsuit against Abbott (NYSE:ALR) - September 2 at 11:33 AM
News IconShares Gapping Lower Before the Open: Alere Inc. (NYSE:ALR) - Post News (NYSE:ALR) - September 1 at 3:26 PM
News IconWall Street Ratings and Update on Alere Inc. (NYSE:ALR) - Post News (NYSE:ALR) - August 29 at 4:03 PM logoBenzinga's M&A Chatter for Friday August 26, 2016 - Benzinga (NYSE:ALR) - August 29 at 8:11 AM
News IconAlere Pulls Abbott to Court over Merger Deal (NYSE:ALR) - August 27 at 8:13 AM
News IconAlere Drags Abbott to Court to Force Completion of $5.8 Billion Deal (NYSE:ALR) - August 27 at 8:13 AM logoAlere sues Abbott to complete $5.8B merger (NYSE:ALR) - August 27 at 8:13 AM logoAbbott's Acquisitions in Question as Issues Arise About Alere, St. Jude (NYSE:ALR) - August 27 at 8:13 AM logoAlere sues Abbott over $5.8 billion takeover (NYSE:ALR) - August 26 at 3:26 PM logoUPDATE 2-Alere sues Abbott over $5.8 bln takeover (NYSE:ALR) - August 26 at 2:23 PM logoUPDATE 1-Alere drags Abbott to court over $5.8 bln deal (NYSE:ALR) - August 26 at 1:57 PM logoAlere (ALR) Files Complaint Against Abbott (ABT) Regarding Merger (NYSE:ALR) - August 26 at 11:34 AM logoAlere Issues Statement (NYSE:ALR) - August 26 at 11:34 AM


Alere (NYSE:ALR) Chart for Monday, September, 26, 2016

Last Updated on 9/26/2016 by Staff